Aclaris Therapeutics Inc (ACRS)
1.17
-0.05
(-4.10%)
USD |
NASDAQ |
Apr 24, 16:00
1.19
+0.02
(+1.71%)
Pre-Market: 08:13
Aclaris Therapeutics Shareholders Equity (Quarterly): 157.18M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 157.18M |
| September 30, 2023 | 156.33M |
| June 30, 2023 | 179.75M |
| March 31, 2023 | 176.81M |
| December 31, 2022 | 197.62M |
| September 30, 2022 | 219.84M |
| June 30, 2022 | 235.75M |
| March 31, 2022 | 180.20M |
| December 31, 2021 | 197.34M |
| September 30, 2021 | 216.58M |
| June 30, 2021 | 233.82M |
| March 31, 2021 | 112.29M |
| December 31, 2020 | 37.65M |
| September 30, 2020 | 40.76M |
| June 30, 2020 | 49.37M |
| March 31, 2020 | 58.18M |
| December 31, 2019 | 69.91M |
| September 30, 2019 | 85.28M |
| Date | Value |
|---|---|
| June 30, 2019 | 137.23M |
| March 31, 2019 | 182.25M |
| December 31, 2018 | 215.12M |
| September 30, 2018 | 146.33M |
| June 30, 2018 | 174.20M |
| March 31, 2018 | 200.47M |
| December 31, 2017 | 225.26M |
| September 30, 2017 | 244.26M |
| June 30, 2017 | 168.14M |
| March 31, 2017 | 160.29M |
| December 31, 2016 | 169.49M |
| September 30, 2016 | 81.12M |
| June 30, 2016 | 90.24M |
| March 31, 2016 | 83.21M |
| December 31, 2015 | 92.52M |
| September 30, 2015 | -38.12M |
| June 30, 2015 | 10.80M |
| December 31, 2014 | -20.76M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
37.65M
Minimum
Dec 2020
235.75M
Maximum
Jun 2022
144.31M
Average
157.18M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
| Aldeyra Therapeutics Inc | 119.80M |
| Akoya Biosciences Inc | 53.77M |
| MSP Recovery Inc | 272.39M |
| Bullfrog AI Holdings Inc | 2.592M |
| Cadrenal Therapeutics Inc | 7.692M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 197.40M |
| Total Liabilities (Quarterly) | 40.23M |
| Current Ratio | 4.163 |